Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
CombiRx for MS not better than monotherapy
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Preclinical studies of sex differences: a clinical perspective.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Teriflunomide in multiple sclerosis: Added benefit not proven
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Burden of neurological conditions in Canada.

Pages